Effects of Taekwondo Match-Simulated Fatigue on Balance Performance in Female Athletes
14. september 2026 oppdatert av: Berkay Löklüoğlu
Effects of Taekwondo Match-Simulated Fatigue on Static and Dynamic Balance Performance in Female Athletes
Taekwondo is a high-intensity combat sport characterized by repeated explosive kicking actions and rapid changes in body position, requiring well-developed postural control to maintain technical performance and reduce injury risk.
Although fatigue has been reported to impair balance performance, previous studies have primarily induced fatigue using non-specific laboratory protocols that do not adequately reflect the physiological and neuromuscular demands of taekwondo competition.
Consequently, the effects of taekwondo-specific fatigue on static and dynamic balance performance remain insufficiently understood.
The primary objective of this study will be to investigate the effects of a taekwondo match-simulated fatigue protocol on static and dynamic balance performance in female taekwondo athletes.
Eighteen competitive female taekwondo athletes will participate in this single-group repeated-measures study.
Following a familiarization session, participants will complete a standardized taekwondo match-simulated fatigue protocol consisting of three 2-minute rounds separated by 1-minute passive recovery periods, replicating the official Olympic competition format.
Static and dynamic balance performance will be assessed before and immediately after the fatigue protocol using the Biodex Balance System (Biodex Medical Systems Inc., Shirley, NY, USA).
Balance performance will be evaluated under static and dynamic testing conditions, and the Overall Stability Index, Anteroposterior Stability Index, and Mediolateral Stability Index will be recorded.
The findings of this study are expected to improve understanding of the acute effects of sport-specific fatigue on postural control in female taekwondo athletes and may contribute to the development of evidence-based training and injury prevention strategies.
Studieoversikt
Status
Fullført
Forhold
Studietype
Intervensjonell
Registrering (Faktiske)
20
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Konya, Tyrkia (Türkiye)
- Selcuk University
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Female taekwondo athletes aged 18-20 years.
- Regular participation in taekwondo training (minimum 3 sessions per week).
- Minimum of 3 years of competitive taekwondo experience.
- Free from musculoskeletal injury at the time of testing.
- Willingness to provide written informed consent
Exclusion Criteria:
- Any musculoskeletal injury within the previous 6 months.
- Neurological, vestibular, or balance disorders.
- Lower-extremity surgery within the previous 12 months.
- Any medical condition preventing participation in maximal exercise.
- Failure to complete the testing protocol
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Experimental research design
Female taekwondo athletes will complete a standardized taekwondo match-simulated fatigue protocol.
Static and dynamic balance performance will be assessed immediately before and after the fatigue protocol during a single experimental session.
|
Participants will perform a standardized taekwondo match-simulated fatigue protocol designed to reproduce the physiological and neuromuscular demands of an official taekwondo match.
Static and dynamic balance performance will be evaluated immediately before and after completion of the protocol.
Static balance performance will be assessed using the Biodex Balance System (Biodex Medical Systems Inc., Shirley, NY, USA).
Mean Overall Stability Index (OSI) score, mean Anteroposterior Stability Index (APSI) score, and mean Mediolateral Stability Index (MLSI) score will be calculated automatically by the system.
The static balance condition will be combined with an eyes-closed stance with the platform locked at a static level (a fixed support); this condition will designed to reflect support-fixed, vision-deprived postural control, where the participant must maintain postural stability without visual cues on a stable surface.
Dynamic balance performance will be assessed using the Biodex Balance System (Biodex Medical Systems Inc., Shirley, NY, USA).
Mean Overall Stability Index (OSI) score, mean Anteroposterior Stability Index (APSI) score, and mean Mediolateral Stability Index (MLSI) score will be calculated automatically by the system.
The dynamic balance condition combines an eyes-open stance with the platform stability set to level 5 (an unstable platform that requires active postural adjustments).
This condition will be designed to reflect visually guided, mechanically unstable postural control, where the participant must rely on real-time visual feedback to compensate for continuous platform tilt.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Mean Overall Stability Index (OSI) Score
Tidsramme: Baseline and immediately after the taekwondo match-simulated fatigue protocol.
|
The Mean Overall Stability Index Score is the arithmetic mean of Overall Stability Index values automatically calculated by the Biodex system at the end of each 20-second single-leg stance trial.
This index is a unitless score representing the standard deviation of platform tilt about both the anteroposterior and mediolateral axes combined; it reflects composite postural sway during the trial.
Each participant completed the trial barefoot on her dominant lower extremity, under two within-subject conditions: (i) dynamic balance (eyes-open stance with the Biodex platform stability set to level 5), and (ii) static balance (eyes-closed stance with the platform locked at a static level).
The index is a unitless score representing the standard deviation of platform tilt about the corresponding axis; the theoretical minimum score is 0, which represents perfect postural stability.
There is no fixed theoretical upper limit of these indices.
Higher scores indicate poorer balance performance.
|
Baseline and immediately after the taekwondo match-simulated fatigue protocol.
|
|
Mean Mediolateral Stability Index (MLSI) Score
Tidsramme: Baseline and immediately after the taekwondo match-simulated fatigue protocol.
|
The Mean Mediolateral Stability Index Score is the arithmetic mean of Mediolateral Stability Index values automatically calculated by the Biodex Balance System at the end of each 20-second single-leg stance trial.
This index is a unitless score representing the standard deviation of platform tilt about the frontal axis only; it reflects mediolateral sway and is associated with hip-abductor-driven postural control.
Each participant will complete the trial barefoot on her dominant lower extremity (the foot preferred for kicking a ball) under two within-subject conditions: (i) dynamic balance (eyes-open stance with the Biodex platform stability set to level 5), and (ii) static balance (eyes-closed stance with the platform locked at a static level).
Theoretically, this index has a minimum value of 0, which represents perfect postural stability; there is no fixed theoretical upper limit.
Higher scores indicate poorer balance performance.
|
Baseline and immediately after the taekwondo match-simulated fatigue protocol.
|
|
Mean Anterior-Posterior Stability Index (APSI) Score
Tidsramme: Baseline and immediately after the taekwondo match-simulated fatigue protocol.
|
The Mean Anterior-Posterior Stability Index Score is the arithmetic mean of Anterior-Posterior Stability Index values automatically calculated by the Biodex system at the end of each 20-second single-leg stance trial.
This index is a unitless score representing the standard deviation of platform tilt about the sagittal axis only; it reflects anteroposterior sway and is associated with the ankle strategy of postural control.
Each participant will complete the trial barefoot on her dominant lower extremity (the foot preferred for kicking a ball) under two within-subject conditions: (i) dynamic balance (eyes-open stance with the Biodex platform stability set to level 5), and (ii) static balance (eyes-closed stance with the platform locked at a static level).
Theoretically, this index has a minimum value of 0, which represents perfect postural stability; there is no fixed theoretical upper limit.
Higher scores indicate poorer balance performance.
|
Baseline and immediately after the taekwondo match-simulated fatigue protocol.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Mean Age
Tidsramme: Only baseline.
|
The mean chronological age of participants at the time of enrollment will be reported in years.
Age will be derived from each participant's official identification date of birth and the calendar date of the first balance testing session.
It will be used solely as a descriptive baseline demographic variable.
|
Only baseline.
|
|
Mean Body Mass Index
Tidsramme: Only baseline.
|
Mean Body Mass Index is the arithmetic mean of participant-level BMI values aggregated from body mass (kg) and height (m) according to the standard formula BMI = body mass (kg) / height² (m²).
Body mass will be measured in kilograms and standing height in centimeters by a single trained experimenter during the enrollment session.
Each participant-level BMI is therefore a single aggregated value derived from two distinct unit-of-measure measurements; height (centimeters) and body mass (kilograms) are not reported separately.
It will be used solely as a descriptive baseline demographic variable.
|
Only baseline.
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. juni 2026
Primær fullføring (Faktiske)
1. juli 2026
Studiet fullført (Faktiske)
1. august 2026
Datoer for studieregistrering
Først innsendt
25. juli 2026
Først innsendt som oppfylte QC-kriteriene
30. juli 2026
Først lagt ut (Faktiske)
5. august 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
17. september 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
14. september 2026
Sist bekreftet
1. august 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 279
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .